缩乳术后并发症:2005-2010 年 NSQIP 数据集 3538 例回顾。
Complications following reduction mammaplasty: a review of 3538 cases from the 2005-2010 NSQIP data sets.
机构信息
Division of Plastic Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Aesthet Surg J. 2014 Jan 1;34(1):66-73. doi: 10.1177/1090820X13515676. Epub 2013 Dec 13.
BACKGROUND
Reduction mammaplasty is an established and effective technique to treat symptomatic macromastia. Variable rates of complications have been reported, and there is a continued need for better outcome assessment studies.
OBJECTIVE
The authors investigate predictors of postoperative complications following reduction mammaplasty using the National Surgery Quality Improvement Program (NSQIP) data sets.
METHODS
The 2005-2010 American College of Surgeons NSQIP databases were reviewed to identify primary encounters for reduction mammaplasty using Current Procedural Terminology code 19318. Two complication types were recorded: major complications (deep infection and return to operating room) and any complication (all surgical complications). Preoperative patient factors and comorbidities, as well as intraoperative variables, were assessed. A multivariate regression analysis was used to identify independent predictors of complications.
RESULTS
A total of 3538 patients were identified with an average age of 43 years and body mass index of 31.6 kg/m(2). Most patients underwent outpatient surgery (80.5%) with an average operative time of 180 minutes. The incidence of overall surgical complications was 5.1%. The following factors were independently associated with any surgical complications: morbid obesity (odds ratio [OR], 2.1; P < .001), active smoking (OR, 1.7; P < .001), history of dyspnea (OR, 2.0; P < .001), and resident participation (OR, 1.8; P = .01). The incidence of major surgical complications was 2.1%. Factors associated with major complications included active smoking (OR, 2.7; P < .001), dyspnea (OR, 2.6; P < .001), resident participation (OR, 2.1; P < .001), and inpatient surgery (OR, 1.8; P = .01).
CONCLUSIONS
This study demonstrates overall incidence of complications in 1 in 20 patients and a 1 in 50 incidence of a major surgical complication. Noteworthy findings include the identification of morbid obesity as a significant predictor of overall morbidity and active smoking as a strong predictor of major surgical morbidity. These data can assist surgeons in preoperative counseling and enhance perioperative decision making.
背景
缩乳术是治疗有症状的巨乳症的一种成熟且有效的技术。据报道,其并发症发生率存在差异,因此需要进一步开展研究以更好地评估其治疗效果。
目的
作者使用国家外科质量改进计划(NSQIP)数据库,分析缩乳术后并发症的预测因素。
方法
本研究回顾了 2005-2010 年美国外科医师学会 NSQIP 数据库,采用手术操作分类代码 19318 识别缩乳术的初次就诊病例。记录了两种类型的并发症:主要并发症(深部感染和重返手术室)和任何并发症(所有手术并发症)。评估了术前患者因素和合并症以及术中变量。采用多变量回归分析确定并发症的独立预测因素。
结果
共纳入 3538 例患者,平均年龄为 43 岁,体重指数为 31.6 kg/m2。大多数患者接受了门诊手术(80.5%),平均手术时间为 180 分钟。总的手术并发症发生率为 5.1%。以下因素与任何手术并发症独立相关:病态肥胖(比值比[OR],2.1;P<0.001)、吸烟(OR,1.7;P<0.001)、呼吸困难史(OR,2.0;P<0.001)和住院医师参与手术(OR,1.8;P=0.01)。主要手术并发症的发生率为 2.1%。与主要并发症相关的因素包括吸烟(OR,2.7;P<0.001)、呼吸困难(OR,2.6;P<0.001)、住院医师参与手术(OR,2.1;P<0.001)和住院手术(OR,1.8;P=0.01)。
结论
本研究显示,20 例患者中约有 1 例出现并发症,50 例患者中约有 1 例出现严重手术并发症。值得注意的是,病态肥胖是整体发病率的一个重要预测因素,吸烟是严重手术发病率的一个重要预测因素。这些数据可以帮助外科医生进行术前咨询,并增强围手术期决策。